Beta antagonist is one of the most effective and the least toxic pharmacological treatments to attenuate the raised catecholamine effects for burned patients. To evaluate the effectiveness and safety of… Click to show full abstract
Beta antagonist is one of the most effective and the least toxic pharmacological treatments to attenuate the raised catecholamine effects for burned patients. To evaluate the effectiveness and safety of beta blocker compared with placebo or usual care in burned patients, a meta‐analysis of randomised controlled trials (RCTs) was conducted. We searched the database of PubMed, Embase, the Cochrane Library, and Web of Science to 10 April 2020. Two investigators independently assessed articles for inclusion and exclusion criteria and selected studies for the final analysis. We performed the meta‐analysis using a random‐effect model. A total of 12 RCTs were included in the study, including 1887 patients. Propranolol‐treated patients have a decrease in length of hospital stay in adults (weighted mean difference [WMD] = −9.06, 95% CIs = [−12.88, −5.24]) and prepare time of graft (WMD = −7.88, 95% CIs = [−12.27, −3.50]). Similarly, the use of propranolol could significantly decrease heart rate (WMD = −15.16, 95% CIs = [−20.37, −9.94]), rate pressure product (WMD = −1.32, 95% CIs = [−1.67, −0.97]), and mean arterial pressure (WMD = −2.75, 95% CIs = [−4.23, −1.26]). Moreover, there is no significant difference between propranolol and placebo with respect to mortality (risk difference [RD] = 0.00, 95% CIs [−0.03, 0.04]), sepsis (RD = −0.03, 95% CIs [−0.09, 0.03]), and events of post‐traumatic stress disorder (PTSD) and acute stress disorder (RD = −0.01, 95% CIs [−0.07, 0.05]), and also, there is no significant difference in subgroup analysis based on age. The use of beta antagonist in burned patients does reduce length of hospital stay in adults, shorten the preparation time for graft, and reduce heart burden, without increasing mortality, sepsis, or PTSD compared with those who had usual care or placebo. So beta antagonist can be considered as an appropriate treatment strategy in burned patients. More prospective, randomised‐controlled, multi‐centre studies were needed to define their place in therapeutic algorithms.
               
Click one of the above tabs to view related content.